Suhail Kraiem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suhail Kraiem has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Mohammed Al-Maadheed
Anti-Doping Lab Qatar, Doha P.O. Box 27775, Qatar
2 shared publications A S Al-Menhali
Anti-Doping Laboratory Qatar, Doha, Qatar
1 shared publicationAlka Beotra
Anti-Doping Laboratory Qatar, Sports City Road, Doha, 27775, Qatar
1 shared publication- Alka Beotra
Anti‐Doping Laboratory Qatar Doha Qatar
1 shared publication Asmaa Raees
Anti-Doping Laboratory Qatar, Sports City Road, Doha, 27775, Qatar
1 shared publicationC Georgakopoulas
Anti-Doping Laboratory Qatar, Doha, Qatar
1 shared publication
Latest Publications
- Open Access
- 7 July 2022
- Published by Taylor & Francis in Future Science OA
- Vol. 8 (6) , FSO805
Downregulation of CYP17A1 By 20-hydroxyecdysone: Plasma Progesterone and Its Vasodilatory Properties
Aim: To investigate the effect of 20-hydroxyecdysone on steroidogenic pathway genes and plasma progesterone, and its potential impact on vascular functions. Methods: Chimeric mice with humanized li... Plain language summary The study looked at how the level of the hormone progesterone might be changed by taking a steroid called 20-hydroxyecdysone, which can be found in dietary supplements, and h... Graphical abstract
- 7 July 2022
- Published by Taylor & Francis in Future Science OA
- Vol. 8 (6) , FSO805
Open AccessDownregulation of CYP17A1 By 20-hydroxyecdysone: Plasma Progesterone and Its Vasodilatory Properties
Aim: To investigate the effect of 20-hydroxyecdysone on steroidogenic pathway genes and plasma progesterone, and its potential impact on vascular functions. Methods: Chimeric mice with humanized li... Plain language summary The study looked at how the level of the hormone progesterone might be changed by taking a steroid called 20-hydroxyecdysone, which can be found in dietary supplements, and h... Graphical abstract
- Open Access
- 23 March 2021
- Published by Wiley in Drug Testing and Analysis
- Vol. 13 (7) , 1341-1353
Analytical strategy for the detection of ecdysterone and its metabolites in vivo in uPA(+/+)‐SCID mice with humanized liver, human urine samples, and estimation of prevalence of its use in anti‐doping samples
Ecdysteroids are of interest as potential sport performance enhancers, due to their anabolic effects. The current study aimed to analyze levels of the most abundant ecdysteroid, ecdysterone (20‐hydroxyecdysone, 20‐OHE) in easily available dietary supplements, and, outline an analytical strategy for its detection, and that, of its metabolites, (1) following administration of pure 20‐OHE to uPA(+/+)‐SCID mice with humanized liver, (2) in a human volunteer after ingestion of two supplements, one with a relatively low, and the other a high, concentration of 20‐OHE, and, (3) to estimate the prevalence of use of 20‐OHE in elite athletes (n = 1000). Of the 16 supplements tested, only five showed detectable levels of 20‐OHE, with concentrations ranging from undetectable up to 2.3 mg per capsule. Urine of uPA(+/+)‐SCID urine showed the presence of 20‐OHE and its metabolite, 14 deoxy ecdysterone, within 24 hours (hr) of ingestion. In humans, both the parent and the metabolite were detectable within 2 to 5 hr of ingestion, with the metabolite being detectable for longer than the parent. After ingestion of a low dose supplement, the parent and metabolite were detectable for 70 and 48 hr, while following the higher dose it was 96 and 48 hr, respectively. Analysis of urines from athletes (n = 1000) confirmed four positives for 20‐OHE, suggesting a prevalence of use of 0.4%. Prevalence of its use by elite athletes was relatively low, however, this needs to be confirmed in other populations, and with other related ecdysteroids.
- 23 March 2021
- Published by Wiley in Drug Testing and Analysis
- Vol. 13 (7) , 1341-1353
Open AccessAnalytical strategy for the detection of ecdysterone and its metabolites in vivo in uPA(+/+)‐SCID mice with humanized liver, human urine samples, and estimation of prevalence of its use in anti‐doping samples
Ecdysteroids are of interest as potential sport performance enhancers, due to their anabolic effects. The current study aimed to analyze levels of the most abundant ecdysteroid, ecdysterone (20‐hydroxyecdysone, 20‐OHE) in easily available dietary supplements, and, outline an analytical strategy for its detection, and that, of its metabolites, (1) following administration of pure 20‐OHE to uPA(+/+)‐SCID mice with humanized liver, (2) in a human volunteer after ingestion of two supplements, one with a relatively low, and the other a high, concentration of 20‐OHE, and, (3) to estimate the prevalence of use of 20‐OHE in elite athletes (n = 1000). Of the 16 supplements tested, only five showed detectable levels of 20‐OHE, with concentrations ranging from undetectable up to 2.3 mg per capsule. Urine of uPA(+/+)‐SCID urine showed the presence of 20‐OHE and its metabolite, 14 deoxy ecdysterone, within 24 hours (hr) of ingestion. In humans, both the parent and the metabolite were detectable within 2 to 5 hr of ingestion, with the metabolite being detectable for longer than the parent. After ingestion of a low dose supplement, the parent and metabolite were detectable for 70 and 48 hr, while following the higher dose it was 96 and 48 hr, respectively. Analysis of urines from athletes (n = 1000) confirmed four positives for 20‐OHE, suggesting a prevalence of use of 0.4%. Prevalence of its use by elite athletes was relatively low, however, this needs to be confirmed in other populations, and with other related ecdysteroids.